Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Neurology
•
Behavioral Neurology
•
Behavioral Neurology & Neuropsychiatry
How does the microbiome factor into neurodegenerative diseases?
Related Questions
Would you consider AEDs in patients with recurrent TGA?
How long after a motor vehicle accident would you expect symptoms including memory loss, hypersomnia, and mood changes to be attributable to the accident?
How will you counsel patients regarding ARIA?
Is it possible to develop worsening motor features of Parkinson's disease (PD) when using clozapine (for treatment of PD psychosis) above a certain dose?
How do you implement brexpiprazole for treatment of agitation in Alzheimer’s patients?
How do you manage the manifestations of Creutzfeldt-Jakob disease?
What lifestyle choices are helpful in reducing the risk of or slowing cognitive decline?
What makes a patient a good candidate for treatments targeting amyloid such as lecanemab or donanemab?
Is there a point at which further reduction in amyloid burden is no longer clinically meaningful or should the goal always be as much reduction as possible?
How do you evaluate patients with suspected pseudo-dementia?
